Bone Neoplasm
18
2
4
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
2 terminated out of 18 trials
81.8%
-4.7% vs benchmark
11%
2 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases
Functional Recovery of Patients Undergoing Resection and Reconstruction of the Lower Limbs for Bone Tumor.
Safety and Efficacy of Non-Setting Paste in Bone Defect Reconstruction
Early Recovery After "Wedge Resection" Surgery to Remove Lung Mestastasis Secondary to Bone Cancer.
9-ING-41 in Patients with Advanced Cancers
Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis
Multicentric Bone Tumor Imaging Report and Data System
Retrospective Case Series of COVID19+ Patients Undergoing Orthopedic Surgery
Cross Cultural Validation of the Italian Version of the Bt-DUX
Proposal for Intraoperative Administration of Intravenous Indocyanine Green to Evaluate Position of the Optic Canal, Position of the Internal Carotid Arteries, Tumor Vascularization, and Vessel Encasement in Endoscopic Endonasal Cranial Base Surgery
Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute
Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II
Distal Tibia Sarcoma Treatment Using Allograft Arthrodesis of the Ankle
A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.
A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain
MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases